Screener
CorMedix CRMD Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $355.15M+618% | $257.68M+61.6% | $179.08M+170% | $145.83M+258% | $49.48M+39.8% | ||
| $0-100% | $0-100% | $0-100% | $3.69M-66.5% | $7.22M-32.8% | ||
| $76.71M-51.6% | $161.31M+276% | $154.81M+183% | $171.23M+231% | $158.57M+812% | ||
| $43.14M+49.2% | $38.58M+300% | $30.73M+310% | $29.72M+291% | $28.92M+335% | ||
| $502.99M+93.8% | $480.55M+93.7% | $383.11M+164% | $367.05M+220% | $259.54M+255% | ||
| $8.56M+97.0% | $7.85M+378% | $6.17M+257% | $5.96M+226% | $4.35M+129% | ||
| $30M+71.3% | $30M— | $30M— | $30M— | $17.52M— | ||
| $348.17M+36.7% | $358.47M+20,499% | $368.77M+20,476% | $379.07M+20,455% | $254.61M+13,328% | ||
| $917.75M+22.2% | $904.05M+258% | $815.64M+445% | $826.14M+595% | $750.86M+868% | ||
| $10.33M-49.5% | $10.24M+76.1% | $12.83M+564% | $7.88M+358% | $20.45M+1,422% | ||
| $207.29M+55.1% | $187.4M+491% | $128.78M+274% | $174.27M+415% | $133.64M+623% | ||
| $456.04M+21.1% | $443.22M+1,286% | $378.59M+991% | $420.84M+1,131% | $376.73M+1,896% | ||
| 79K-100.0% | 160M0.0% | 160M0.0% | 160M0.0% | 160M0.0% | ||
| -$126.71M+33.5% | -$111.99M+62.6% | -$137.97M+56.7% | -$176.58M+48.0% | -$190.6M+46.0% | ||
| $461.71M+23.4% | $460.83M+109% | $437.05M+280% | $405.31M+379% | $374.13M+537% | ||
| $917.75M+22.2% | $904.05M+258% | $815.64M+445% | $826.14M+595% | $750.86M+868% |
FAQ
- What are CorMedix's total assets?
- CorMedix (CRMD) holds $917.7M in total assets, up 22.2% year over year.
- How much cash does CorMedix have?
- CorMedix holds $355.2M in cash and equivalents.
- Can CorMedix cover its short-term obligations?
- Its current ratio is 2.43 — current assets exceed current liabilities.
- Where does CorMedix's balance sheet data come from?
- Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
